Description: SomnoMed is a publicly traded company founded in 2004 in Sydney, Australia. To date there have been over 200,000 patients around the world who have been treated with SomnoDent. Our world class devices are designed with our patients comfort at the top of mind and we are proud to have the longest lasting device and the best service system in place to satisfy not only patients, but dentists, physicians and payers as well. SomnoMed is making unique investments in a medical initiative to increase physician awareness that oral device treatment is an extremely effective method of treatment in the right patient population. The company is also helping to increase the collaboration between dentists and physicians, which will improve the sleep health of patients suffering from obstructive sleep apnea.
Home Page: somnomed.com/au/
20 Clarke Street
Crows Nest,
NSW
2065
Australia
Phone:
61 2 9467 0400
Officers
| Name | Title |
|---|---|
| Mr. Neil Verdal-Austin B.Com., C.A. | Global CEO, MD & Director |
| Mr. Hervé Fiévet | Global Chief Financial Officer |
| Mr. Mark Harding | VP of Global Marketing |
| Mr. Matthew Conlon | Exec. VP Sales & Marketing - North America |
| Mr. Marco Van Kleef | VP of Marketing & Sales - Europe |
| Dr. Jagdeep Bijwadia | Chief Medical Officer |
| Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., CA, SF FIN | Company Sec. |
| Dr. Peter Spencer MBA Ph.D., MAICD | Gen. Mang. of Operations |
| Mr. Christopher Bedford | VP of Global Production and Product Devel. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.087 |
| Price-to-Sales TTM: | 1.0562 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |